Newrotex
Newrotex is a UK-based biotech firm dedicated to developing innovative silk-based medical solutions for the nervous system, particularly in the area of peripheral nerve repair. The company aims to disrupt existing surgical approaches by providing off-the-shelf solutions that eliminate the need for autografts, thereby improving patient outcomes and reducing recovery times.
What We Do
Newrotex’s initial product is a silk conduit designed for peripheral nerve repair, addressing the unmet need in long-length nerve repairs. The silk conduits promote guided nerve growth and have shown superior axonal regeneration compared to traditional autografts in preclinical trials.
Regenerative Medicine
Application Area
Key People
Founder - CEO
Chief Science Officer
Chief Commercial Officer
Research Scientist
Company Secretary
Chairman
News & Updates
Location: Oxford, UK. Details and registration can be found here: https://app.medall.org/event-listings/6th-annual-oxford-surgical-innovation-conference
The article describes some of the incredible uses of silk and the work we’re doing to bring a new standard of treatment for patients who have suffered catastrophic nerve injuries. Check out the article on the University of Oxford website.
Newrotex was selected by the ASPS Plastic Surgery Accelerator powered by MedTech Innovator, and featured as one of 5 best-in-class startups. Newrotex Ltd was awarded Runner-Up.
Newrotex was selected to join the prestigious MedTech Innovator programme, recognizing the potential of its regenerative silk technology to address the unmet need for effective treatments for nerve injuries.